'Euboxia' (from the Greek 'eu' meaning good, normal or happy, and 'box' from the tradition of writing physiological variables in boxes) is a colloquial word used in many North American and other hospitals to describe the state of apparent perfection aimed at by residents by the time they present their patients on morning rounds. The term is used generally with irony or even sarcasm, as even the most junior medical student appreciates that while modern medicine can 'fix' just about any physiological variable (albeit at times only with measures such as mechanical ventilation and extracorporeal renal and cardiac support), our power to confer immortality remains elusive. Despite this clear disconnection between our ability to correct the parameters we can measure and our inability to correct the unmeasurable, much of the focus of critical care medicine throughout its history has been on restoring physiological variables to the 'normal' (by which is meant 'normal in health') range. This is now starting to change.
Abnormally high or low values for virtually any physiological parameter are associated with poorer outcome. Indeed, even values that fall in the higher zone of a statistically-defined 'normal range' are associated with higher mortality 1 , an observation that highlights the difference between the concept of what is common (or 'normal') and what is associated with the best outcome (or 'healthy') in a particular patient state. A disappointing feature of critical care medicine research has been the realisation that normalising many physiological parameters often does not benefit the patient, and indeed that the interventions employed to do this can cause harm. For example, normalising intracranial pressure in traumatic brain injury by early decompressive craniectomy 2 , arterial blood pressure in sepsis by inhibition of nitric oxide synthase 3 , urine output in acute renal impairment using dopamine 4 , haemoglobin (when not bleeding) by transfusion 5 , and blood glucose using an insulin infusion 6 . Furthermore, adjusting some treatments to produce abnormal physiological parameters leads to better outcomes, as is the case with permissive hypercapnia in acute respiratory distress syndrome 7 . An alternative approach to 'euboxia' is to aim for physiological levels that, in obser-vational studies, characterise survivors (for example, supranormal oxygen delivery) 8 . While this might have been a successful approach if low tissue oxygen delivery was causally related to adverse outcome and if the risk of the intervention was less than its benefit, unfortunately this proved not to be the case 9, 10 . Some physiological parameters doggedly resist the application of an evidencebased approach, perhaps because they are such an intuitive part of everyday life. For example, the management of reduced urine output in acute renal impairment by many junior (and some senior) doctors, who often seem obliged to ride the fluidfrusemide merry-go-round at least a few times while the patient improves or deteriorates regardless. Fortunately, the need to examine the utility of 'fixing' still more abnormal physiological parameters is becoming widely appreciated, with nascent research programs examining regularity of bowel movements 11 and the control of fever in critical illness 12 . Maintenance of 'adequate' arterial oxygenation to date, however, has been almost off-limits to research-a sacred entity preserved, like other holy things, by belief rather than evidence. It is on this background that the study by Panwar and colleagues 13 in this issue of Anaesthesia and Intensive Care is timely.
Panwar and colleagues at the Alfred Hospital in Melbourne hypothesised that patients in their intensive care unit were spending long periods of time with more than necessary oxygenation levels. This hypothesis would be more meaningful if we really knew what 'necessary oxygenation levels' in critical illness were. Of course, as the study notes, we don't know that, and so in the absence of better information the investigators used levels in excess of the upper limits of the target ranges for pulse oximeter haemoglobin oxygen saturation (SpO 2 ) and partial pressure of arterial oxygen (PaO 2 ) (95% and 80 mmHg) in two large clinical trials as their definition for 'liberal' oxygenation. In their retrospective analysis of oxygen data collected as part of the routine clinical care of 101 patients mechanically ventilated for ≥48 hours up to the first seven days of ventilation, they found patients were generally ventilated with settings that achieved liberal oxygenation, typified by their observation Editorial The pursuit of oxygen euboxia Anaesth Intensive Care 2013; 41: 453-455 that, overall, a time-weighted average fraction of inspired oxygen (FiO 2 ) of 0.42 was used to achieve a time weighted average SpO 2 of 97.1% for the initial seven days of mechanical ventilation. There was greater heterogeneity of practice for patients with worse lung injury, beginning when the FiO 2 requirement exceeded 0.35, with large variations in the SpO 2 and PaO 2 achieved for patients with similar lung injury scores. The authors conclude that, on the basis of heterogeneity of practice but general divergence from guidelines, a randomised controlled trial comparing what they identify as the current liberal approach with a 'conservative' approach closer to that considered acceptable in previous major clinical trials is feasible and warranted. The study's characterisation of current practice is an essential piece of information to inform the design of such a trial.
The study's conclusion that a randomised clinical trial of oxygen targets is feasible is correct insofar as it supports the notion of clinical equipoise, although this would need to be confirmed in hospitals other than their own (as the authors recognise). Substantial practice variability in the control arm of any trial is problematic, and the authors therefore correctly suggest their study's results show management in a trial control arm would need to be protocolised in some way. Whether such a trial is warranted is a different matter. This study and all others have found no clear evidence that oxygenation strategy affects outcome in critical illness. Some would argue there is merit in adopting a consistent clinical approach to any disease condition, even if variations from this approach seemingly have no detriment. Standardised protocols have certainly been associated with improved outcome 14, 15 , even when their content relies on imperfect evidence. So shouldn't we simply protocolise a strategy-any strategy-and audit its results? In the case of oxygen, probably not. There is emerging certainty that therapeutic oxygen is a double-edged sword. Higher FiO 2 and/or SpO 2 / PaO 2 produce damaging reactive oxygen species, reduce cardiac output and cause coronary and peripheral vasoconstriction, atelectasis, and ventilation perfusion mismatch 16 . Whether these effects are worse than those of subnormal SpO 2 /PaO 2 in ventilated intensive care unit patients is simply not known, but there is at least some evidence from studies of myocardial infarction 17 and cardiac arrest 18 that the net effect of overly liberal oxygenation may be an increased mortality in at least some forms of critical illness.
The study by Panwar et al is therefore one of the first steps on a journey that may ultimately lead us to re-evaluate the most fundamental of our euboxic goals in intensive care medicine. The diverse practices identified suggest that clinicians, in the absence of an evidence-based target, are firing the potentially lethal weapon of FiO 2 in a random fashion in the blind hope of hitting something useful without doing collateral damage. Such random behaviour seldom characterises good practice. Clinicians, rightly and as shown in the study, typically do not follow guidelines based on poor evidence. The only acceptable next step is therefore a clinical trial along the lines suggested.
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